ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1686

Rule-Based Algorithm Using Systemic Lupus International Collaborating Clinics (SLICC) Classification Criteria to Identify Patients with Systemic Lupus Erythematosus (SLE) from Electronic Health Record (EHR) Data

Anika S. Ghosh1, Theresa L. Walunas2, Kathryn L. Jackson1, Ahn H. Chun3, Daniel L. Erickson3, Karen Mancera-Cuevas4, Abel N. Kho3 and Rosalind Ramsey-Goldman5, 1Center for Health Information Partnerships, Northwestern University, Chicago, IL, 2Department of Medicine, Division of General Internal Medicine and Geriatrics, Northwestern University, Chicago, IL, 3Northwestern University, Chicago, IL, 4Rheumatology, Northwestern University, Chicago, IL, 5FSM, Northwestern University, Chicago, IL

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Big data, classification criteria and systemic lupus erythematosus (SLE), Electronic Health Record

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Systemic Lupus Erythematosus – Clinical Poster II: Biomarkers and Outcomes

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic Lupus Erythematosus (SLE) is an autoimmune disease that can affect many parts of the body including skin, lungs, brain, heart, kidneys, joints, and blood vessels. How lupus looks in one patient is different than in another patient. Because of this, it is hard to diagnose a patient as having SLE. EHRs are widely used in healthcare settings and are a rich source of information about patients that can be mined for earlier diagnosis identification.

Methods: We identified 513 patients we knew had SLE from the Chicago Lupus Database (CLD) in the Northwestern Medicine Electronic Data Warehouse (NMEDW). We built an algorithm of SLICC classification criteria using ICD9/10 and labs to see if we are finding the same SLICC classification criteria that are in the CLD. According to SLICC classification rules, to have definite lupus you need at least 1 clinical criteria, at least 1 immunologic criteria, and a total of 4 or more criteria.

Results: As shown in Table 1, of 513 patients with SLE in the CLD, we detected the following SLICC classification criteria correctly in the NMEDW: clinical- chronic cutaneous 97%; acute cutaneous 98%; renal 65%; serositis 52%; arthritis 34%; neuro 29%; ulcers 16%; alopecia 3%; and labs – thrombocytopenia 99%; dsDNA 89%; hemolytic anemia 80%; complement 74%; leukopenia/ lymphopenia 73%; Anti-Sm Antibody 72%;  Antiphospholipid Antibodies 64%; Antinuclear Antibody 60%; Coombs 17%; Of the 513 patients with SLE in the CLD, all had at least 1 clinical criteria, 469 had at least 1 immunologic criteria, and 498 had 4 or more criteria. Using EHR data from the NMEDW and rules for the SLICC classification criteria, we categorized 467/513 (91%) patients as having definite lupus correctly.

Conclusion: Based the results, we are able to capture over 90% of patients in the NMEDW correctly. Future work includes implementing NLP on criteria like alopecia, oral ulcer, arthritis, and renal biopsy to improve identification of individual criteria in EHR data that ICD9/10 and labs missed. Once we develop an algorithm that is able to capture the same criteria in the NMEDW that are in the CLD, we can use that algorithm to identify patients that might have a missed diagnosis of lupus. If we are able to find patients who have lupus earlier in their disease progression, we can improve their quality of care and treat earlier with the goal of minimizing disease damage.

Table 1. SLICC Classification Criteria Identified in CLD and NMEDW

SLICC Criteria

Identified in CLD

(N)

Identified in NMEDW (N)

Identified in CLD and NMEDW (%)

Clinical

 

 

 

acute cutaneous

435

425

98%

Chronic cutaneous

146

141

97%

Renal

182

118

65%

Serositis

221

115

52%

Arthritis

472

161

34%

Neurological

205

59

29%

Oral ulcers

281

46

16%

Alopecia

96

3

3%

LABORATORY

 

 

 

Thrombocytopenia

454

453

100%

Anti-dsDNA Ab

348

310

89%

Hemolytic Anemia

5

4

80%

Complement

500

368

74%

Leukopenia/Lymphopenia

508

369

73%

Anti-Smith antibody

109

79

72%

Anti-phospholipid antibody

131

84

64%

Anti-nuclear antibody

433

259

60%

Coombs

12

2

17%

 


Disclosure: A. S. Ghosh, None; T. L. Walunas, None; K. L. Jackson, None; A. H. Chun, None; D. L. Erickson, None; K. Mancera-Cuevas, None; A. N. Kho, HealthDataLink, Inc, 1; R. Ramsey-Goldman, None.

To cite this abstract in AMA style:

Ghosh AS, Walunas TL, Jackson KL, Chun AH, Erickson DL, Mancera-Cuevas K, Kho AN, Ramsey-Goldman R. Rule-Based Algorithm Using Systemic Lupus International Collaborating Clinics (SLICC) Classification Criteria to Identify Patients with Systemic Lupus Erythematosus (SLE) from Electronic Health Record (EHR) Data [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/rule-based-algorithm-using-systemic-lupus-international-collaborating-clinics-slicc-classification-criteria-to-identify-patients-with-systemic-lupus-erythematosus-sle-from-electronic-health-record/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rule-based-algorithm-using-systemic-lupus-international-collaborating-clinics-slicc-classification-criteria-to-identify-patients-with-systemic-lupus-erythematosus-sle-from-electronic-health-record/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology